Search

everythinglearnresearchcommunity

for

Search:↓

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

Three new types of a skin blistering disease were found, caused by specific gene mutations.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

Colored hair-thickening fibers can help hide hair loss in some people with Epidermolysis Bullosa but may cause scalp irritation.

Children with Epidermolysis Bullosa need better access to specialized dental care.

New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Transplanting a person's own hair can heal chronic wounds in certain skin conditions.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

Fibroblasts from healthy donors can prevent changes seen in recessive epidermolysis bullosa simplex.

Mutations in the KLHL24 gene cause a skin disorder in some Russian families.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

People with Epidermolysis bullosa have many health problems including poor oral health, which is often neglected due to other medical issues.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

The document is a detailed medical reference on skin and genetic disorders.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Combining skin tissue pathology with genetics has greatly improved the diagnosis and understanding of certain skin diseases.

Human skin has multiple layers and functions, with key roles in protection, temperature control, and appearance.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

New treatments targeting specific genes show promise for treating keratin disorders.

The study found that p63 needs signals from morphogens to help skin cells differentiate properly.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.